Everolimus Teva 7,5 mg tabl. België - Engels - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

everolimus teva 7,5 mg tabl.

teva pharma belgium sa-nv - everolimus 7,5 mg - tablet - 7,5 mg - everolimus 7.5 mg - everolimus

EVEROCAN everolimus 0.25 mg tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

everocan everolimus 0.25 mg tablet blister pack

pharmacor pty ltd - everolimus, quantity: 0.25 mg - tablet, uncoated - excipient ingredients: ethanol absolute; lactose monohydrate; butylated hydroxytoluene; magnesium stearate; lactose; acetone; hypromellose; crospovidone - everolimus is indicated for the prophylaxis of organ rejection in adult patients at mild to moderate immunological risk receiving an allogeneic renal or cardiac transplant and in adult patients receiving an allogeneic hepatic transplant (see section 4.4 special warnings and precautions for use).

EVEROCAN everolimus 0.75 mg tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

everocan everolimus 0.75 mg tablet blister pack

pharmacor pty ltd - everolimus, quantity: 0.75 mg - tablet, uncoated - excipient ingredients: hypromellose; butylated hydroxytoluene; ethanol absolute; acetone; crospovidone; lactose; magnesium stearate; lactose monohydrate - everolimus is indicated for the prophylaxis of organ rejection in adult patients at mild to moderate immunological risk receiving an allogeneic renal or cardiac transplant and in adult patients receiving an allogeneic hepatic transplant (see section 4.4 special warnings and precautions for use).

EVEROCAN everolimus 0.5 mg tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

everocan everolimus 0.5 mg tablet blister pack

pharmacor pty ltd - everolimus, quantity: 0.5 mg - tablet, uncoated - excipient ingredients: lactose; ethanol absolute; magnesium stearate; lactose monohydrate; hypromellose; crospovidone; acetone; butylated hydroxytoluene - everolimus is indicated for the prophylaxis of organ rejection in adult patients at mild to moderate immunological risk receiving an allogeneic renal or cardiac transplant and in adult patients receiving an allogeneic hepatic transplant (see section 4.4 special warnings and precautions for use).

Everolimus Dr. Reddy's Tablets 5mg Malta - Engels - Medicines Authority

everolimus dr. reddy's tablets 5mg

reddy pharma iberia s.a. avinguda de josep tarradellas 38 barcelona, 08029, spain - tablet - everolimus 5 mg - antineoplastic agents

Afinitor 5mg Tab 5 mg Jordanië - Engels - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

afinitor 5mg tab 5 mg

شركة مستودع الأدوية الأردني - the jordan drugstore co - everolimus 5 mg - 5 mg

CERTICAN TABLETS 0.25 MG Singapore - Engels - HSA (Health Sciences Authority)

certican tablets 0.25 mg

novartis (singapore) pte ltd - everolimus - tablet - 0.25 mg - everolimus 0.25 mg

CERTICAN TABLETS 0.5 MG Singapore - Engels - HSA (Health Sciences Authority)

certican tablets 0.5 mg

novartis (singapore) pte ltd - everolimus - tablet - 0.5 mg - everolimus 0.5 mg

CERTICAN TABLETS 0.75 MG Singapore - Engels - HSA (Health Sciences Authority)

certican tablets 0.75 mg

novartis (singapore) pte ltd - everolimus - tablet - 0.75 mg - everolimus 0.75 mg

Votubia 2.5mg tablets Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

votubia 2.5mg tablets

novartis pharmaceuticals uk ltd - everolimus - tablet - 2.5mg